Apply existing eye-tracking technology for the development of a state-of-the art digital instrument for orthoptic strabismus measurements. This clever idea by physicist Bob van Dijk is now nearly a reality with Laméris Ootech, a Dutch supplier of orthoptic practice equipment. In his office at VUmc Van Dijk proudly demonstrates his almost perfectly functioning prototype. “A few minor tweaks, a slick design and it’s ready for use”.
According to orthoptist Jacqueline Krijnen, closely involved with the development, the new instrument offers a major step forward in strabismus measurement. Currently a variety of simple handheld devices are used, their relative inaccuracy being the most important factor for the high rate of repeated surgeries in strabismus correction. Krijnen expects the new instrument to significantly improve the surgery results, especially with children who lack the peace and focus required for accurate measurement using the current devices. For Krijnen and Van Dijk the secret to success lies in the close cooperation between technician, clinician and the company involved. For them the contribution of the IXA business developers in initiating and guiding this cooperation has been crucial. Van Dijk: “I’m an inventor, not an entrepreneur or marketeer.” Krijnen: “I really enjoyed the cooperation. I can’t wait to see Bob’s idea becoming clinically relevant.”
By request of the dermatologists at VUmc, Ruud Verdaasdonk has developed a ‘UV-mirror’. It enables people to see whether UV-light has damaged their skin and helps them to assess their sunscreen application skills. “The mirror is a very effective instrument for education and prevention purposes”, says Verdaasdonk, who is not only professor of Biophotonics and […]
With their user-friendly measurement instrument for the quantification of spasticity, Jules Becher and Jaap Harlaar aim to revolutionise therapy in children with spasticity. Becher explains that the cause of spastic muscles can be of neurophysiological or biomechanical origin, each requiring specific therapy. By employing three different sensors the new device can pinpoint the precise cause […]
These are exciting times for Dave Koolbergen, congenital cardiac surgeon at AMC. With his company Haermonics he hopes to bring a new technology to market for postoperative pericardial flushing. It was developed upon his observation that after heart surgery often the removal of accumulated blood and clots can be achieved by flushing the pericardial space […]